TRxADE HEALTH, Inc. (MEDS)

TRxADE HEALTH Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	21	6	4	19	43	-
Market Cap Growth	313.69%	72.74%	-80.53%	-54.98%	-	-
Enterprise Value	16	5	4	17	37	-2
PE Ratio	1.31	-0.36	-1.08	-3.63	-16.88	-
PS Ratio	3.11	0.78	0.37	1.95	2.50	-
PB Ratio	1.52	11.95	4.92	5.11	4.93	-
P/FCF Ratio	-1.10	-3.13	-2.40	-7.44	-19.01	-
P/OCF Ratio	-1.09	-3.13	-2.40	-7.51	-19.33	-
EV/Sales Ratio	2.42	0.65	0.41	1.75	2.19	-0.25
EV/EBITDA Ratio	2.57	-0.34	-1.44	-3.36	-15.60	13.89
EV/EBIT Ratio	3.06	-0.32	-1.35	-3.28	-14.96	8.20
EV/FCF Ratio	-0.69	-2.59	-2.71	-6.70	-16.65	-31.85
Debt / Equity Ratio	0.01	0.39	2.08	0.33	0.07	0.24
Debt / EBITDA Ratio	0.03	-0.01	-0.54	-0.24	-0.26	-7.31
Debt / FCF Ratio	-0.02	-0.10	-1.01	-0.48	-0.28	16.76
Quick Ratio	4.70	0.22	0.80	4.49	9.30	7.08
Current Ratio	4.75	0.24	0.98	4.72	10.95	7.30
Asset Turnover	0.49	0.79	2.06	1.42	1.53	1.62
Interest Coverage	4.26	-13.89	-9.33	-224.34	-85.29	-4.34
Return on Equity (ROE)	66.00%	-622.70%	-202.60%	-95.00%	-25.80%	-10.70%
Return on Assets (ROA)	29.50%	-170.10%	-69.70%	-76.30%	-22.60%	-6.20%
Return on Capital (ROIC)	-93.20%	-966.06%	-124.24%	-105.45%	-26.93%	2.44%
Earnings Yield	19.44%	-275.34%	-92.55%	-27.58%	-5.92%	-
FCF Yield	-54.24%	-32.00%	-41.69%	-13.43%	-5.26%	-
Dividend Yield	78.10%	0.00%	0.00%	0.00%	0.00%	-
Payout Ratio	-473.40%	0.00%	0.00%	0.00%	0.00%	0.00%
Buyback Yield / Dilution	-88.90%	-320.30%	-4.45%	-5.60%	-29.96%	-1.76%
Total Shareholder Return	-88.90%	-320.30%	-4.45%	-5.60%	-29.96%	-1.76%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).